M&T Bank Corp Sorrento Therapeutics, Inc. Transaction History

M&T Bank Corp

  • $30.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.74 - $1.83 $9,406 - $23,262
-12,712 Reduced 46.59%
14,570 $12,000
Q4 2022

Feb 13, 2023
BUY
$0.74 - $1.83 $9,406 - $23,262
12,712 Added 87.25%
27,282 $24,000
Q2 2022

Aug 05, 2022
BUY
$1.24 - $2.33 $18,066 - $33,948
14,570 New
14,570 $7,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email